Illuccix (kit for Ga-68 gozetotide)
Telix's ready-to-label kit that lets any nuclear medicine department make the gallium PSMA scan for prostate cancer.
Overview
Illuccix was approved by the FDA in December 2021 for PET imaging of PSMA-positive lesions in men with suspected metastasis who are candidates for definitive therapy and in men with suspected recurrence based on rising PSA, and in 2025 the label was extended to selecting patients for PSMA radioligand therapy. Gozellix, a second-generation kit with longer post-labelling shelf life, was approved in 2025. Illuccix is also registered in Australia and several other markets. The kit format made PSMA PET available to centres without access to the cyclotron-produced 18F tracers.
- Detector ring
- PSMA ligand
- 511 keV photon pair
1.Illuccix (kit for Ga-68 gozetotide) slips into a pocket on PSMA.
Approvals
| Region | Year | Indication |
|---|---|---|
| US | 2021 | PSMA PET imaging in prostate cancer (initial staging with suspected metastasis; suspected recurrence) |
| Australia | 2021 | PSMA PET imaging in prostate cancer |
| US | 2025 | Gozellix kit; selection of patients for PSMA-targeted radioligand therapy |
Trials
topTrials recruiting now
Country and place are remembered in this browser only. A postcode is sent to OpenStreetMap's Nominatim service to find coordinates when you press the button; nothing else leaves your device.
Notes
top- What a result means: PSMA-avid spots on the scan indicate prostate cancer deposits and decide between local treatment, systemic therapy or radioligand therapy.
Latest papers
topQuery for this drug: (TITLE:"Illuccix" OR ABSTRACT:"Illuccix" OR TITLE:"kit for Ga-68 gozetotide" OR ABSTRACT:"kit for Ga-68 gozetotide" OR TITLE:"Gozellix" OR ABSTRACT:"Gozellix") AND (radiopharmaceutical OR radioligand OR radionuclide OR theranostic OR "nuclear medicine" OR "molecular imaging" OR radiotracer OR scintigraphy OR cancer OR tumor OR tumour OR oncology OR carcinoma OR lymphoma OR leukemia OR leukaemia OR myeloma OR sarcoma OR melanoma OR glioma). Results are unfiltered search hits about Illuccix (kit for Ga-68 gozetotide), not a curated reading list.
Similar pages
not linked directly; found by shared links- AgentFludeoxyglucose F-18 (FDG)
Shares PET/CT, Fluorine-18 and the tag test.
- TermPSMA-RADS (PSMA reporting and data system)
Shares Piflufolastat F-18 / Pylarify TruVu, Gallium-68 gozetotide (PSMA-11), PSMA, Lutetium-177 vipivotide tetraxetan.
- PairingPSMA PET → PSMA radioligand therapy
Shares Piflufolastat F-18 / Pylarify TruVu, Theranostics, PSMA, Lutetium-177 vipivotide tetraxetan.
- Key paperAppropriate use criteria for prostate-specific membrane antigen (PSMA) PET imaging
Shares Piflufolastat F-18 / Pylarify TruVu, Gallium-68 gozetotide (PSMA-11), PSMA PET, Fluorine-18.
- TrialPSMA PET Combined With MRI for the Detection of PCa
Shares Gallium-68 gozetotide (PSMA-11), Telix Pharmaceuticals, Gallium-68, Prostate cancer.
- PersonThomas A. Hope
Shares PSMA theranostics roadmap: antigen discovery → PSMA PET → 177Lu-PSMA-617 → earlier lines and alpha, PSMA, PSMA PET, Gallium-68.
- PersonJohannes Czernin
Shares PSMA, Lutetium-177 vipivotide tetraxetan, PSMA PET, Gallium-68.
- AgentFluciclovine F-18
Shares Biochemical recurrence (BCR), PET/CT, Fluorine-18, Gallium-68.